JP1670202S - - Google Patents

Info

Publication number
JP1670202S
JP1670202S JPD2020-1510F JP2020001510F JP1670202S JP 1670202 S JP1670202 S JP 1670202S JP 2020001510 F JP2020001510 F JP 2020001510F JP 1670202 S JP1670202 S JP 1670202S
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JPD2020-1510F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JPD2020-1510F priority Critical patent/JP1670202S/ja
Priority to TW109303786F priority patent/TWD210643S/zh
Priority to US29/741,736 priority patent/USD968234S1/en
Application granted granted Critical
Publication of JP1670202S publication Critical patent/JP1670202S/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JPD2020-1510F 2020-01-29 2020-01-29 Active JP1670202S (member.php)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JPD2020-1510F JP1670202S (member.php) 2020-01-29 2020-01-29
TW109303786F TWD210643S (zh) 2020-01-29 2020-07-10 手錶本體
US29/741,736 USD968234S1 (en) 2020-01-29 2020-07-15 Wristwatch

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JPD2020-1510F JP1670202S (member.php) 2020-01-29 2020-01-29

Publications (1)

Publication Number Publication Date
JP1670202S true JP1670202S (member.php) 2020-10-19

Family

ID=72840690

Family Applications (1)

Application Number Title Priority Date Filing Date
JPD2020-1510F Active JP1670202S (member.php) 2020-01-29 2020-01-29

Country Status (3)

Country Link
US (1) USD968234S1 (member.php)
JP (1) JP1670202S (member.php)
TW (1) TWD210643S (member.php)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD906137S1 (en) * 2019-03-07 2020-12-29 Patek Philippe Sa Geneve Watch

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD356042S (en) * 1992-04-20 1995-03-07 Seiko Epson Corporation Wrist Watch
USD551100S1 (en) * 2005-01-17 2007-09-18 Seiko Watch Kabushiki Kaisha Watch case
TWD112903S1 (zh) * 2005-03-30 2006-09-11 大豪爾公司 錶殼
USD537368S1 (en) * 2005-05-25 2007-02-27 Casio Keisanki Kabushiki Kaisha Wrist watch
USD739289S1 (en) * 2013-11-01 2015-09-22 Tudor Watch U.S.A., Llc Watch strap
USD718154S1 (en) * 2013-12-20 2014-11-25 Rolex Watch U.S.A., Inc. Watch case
AU364423S (en) * 2015-03-10 2015-09-25 Omega Sa Omega Ag Omega Ltd Watchcase
JP1547575S (member.php) * 2015-03-10 2016-04-11
AU201614769S (en) * 2016-03-01 2016-10-12 Omega Sa Omega Ag Omega Ltd Bezel for a watch
JP1599408S (member.php) * 2017-02-22 2018-03-12
USD820693S1 (en) * 2017-03-17 2018-06-19 Citizen Watch Co., Ltd. Watch
USD943429S1 (en) * 2019-07-08 2022-02-15 Lvmh Swiss Manufactures Sa Watch case
US11687035B2 (en) * 2019-07-30 2023-06-27 Citizen Watch Co., Ltd. Display panel

Also Published As

Publication number Publication date
USD968234S1 (en) 2022-11-01
TWD210643S (zh) 2021-03-21

Similar Documents

Publication Publication Date Title
BR102021007058A2 (member.php)
BR102020022030A2 (member.php)
JP1670202S (member.php)
AR134288A1 (es) UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b
AR134282A1 (es) Compuestos y composiciones farmacéuticas que degradan el regulador de la subfamilia a de la cromatina dependiente de actina asociado a la matriz relacionado con swi / snf
AR134276A1 (es) ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS
AR134275A1 (es) Anticuerpos cd24
AR134271A1 (es) Variantes de cnp, conjugados y formulaciones de los mismos
AR134266A1 (es) Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1
AR134264A1 (es) Correctores farmacológicos de rodopsina y sus usos
AR134263A1 (es) Tratamiento de covid persistente con composición de vesículas extracelulares
AR134262A1 (es) Formulación líquida de agente biológico en almacenamiento estable
AR134259A1 (es) Compuestos de pirimidina bicíclicos, métodos y usos de estos
AR134258A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134257A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134219A1 (es) Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos
AR134214A1 (es) Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central
AR134215A1 (es) Compuestos de tiazol y métodos de uso
AR134200A1 (es) Combinaciones de herbicida / protector a base de herbicidas de la clase de las amidas de ácido n-(1,3,4-oxadiazol-2-il)fenilcarboxílico quirales y sus sales
AR134206A1 (es) Degradantes y usos de los mismos
AR134198A1 (es) Compuestos de proteasa 1 de procesamiento específico de ubiquitina (usp1)
AR134193A1 (es) Métodos para tratar tumores tenosinoviales de células gigantes
AR134194A1 (es) Nuevos moduladores de nitrato, amonio y potasio en plantas y métodos para usarlos
AR134180A1 (es) Péptidos inmunogénicos de magea1, proteínas de unión que reconocen los péptidos inmunogénicos de magea1 y usos de los mismos
AR134185A1 (es) Anticuerpos anti-receptor de transferrina y usos de estos